[go: up one dir, main page]

UA90095C2 - Method for the treatment of endometriosis - Google Patents

Method for the treatment of endometriosis

Info

Publication number
UA90095C2
UA90095C2 UAA200603518A UAA200603518A UA90095C2 UA 90095 C2 UA90095 C2 UA 90095C2 UA A200603518 A UAA200603518 A UA A200603518A UA A200603518 A UAA200603518 A UA A200603518A UA 90095 C2 UA90095 C2 UA 90095C2
Authority
UA
Ukraine
Prior art keywords
endometriosis
nodules
treatment
administration
endenomyomas
Prior art date
Application number
UAA200603518A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Мирудхубашини Говиндараджан
Original Assignee
Мискон Трейдинг С.А.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Мискон Трейдинг С.А. filed Critical Мискон Трейдинг С.А.
Publication of UA90095C2 publication Critical patent/UA90095C2/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Medicinal Preparation (AREA)

Abstract

Endometriosis, including endometriosis externa, endometrioma, adenomyois, endenomyomas, adenomyotic nodules of the uterosacral ligaments, and endometriotic nodules, such as scar endometriosis are effectively treated by the intralesional administration, including transvaginal, endoscopic or open surgical administration including via laparotomy, of a progestogen. Compositions there for also are provided.
UAA200603518A 2003-09-03 2004-08-27 Method for the treatment of endometriosis UA90095C2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US50021703P 2003-09-03 2003-09-03

Publications (1)

Publication Number Publication Date
UA90095C2 true UA90095C2 (en) 2010-04-12

Family

ID=37064580

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200603518A UA90095C2 (en) 2003-09-03 2004-08-27 Method for the treatment of endometriosis

Country Status (3)

Country Link
CN (1) CN1845723B (en)
UA (1) UA90095C2 (en)
ZA (1) ZA200602695B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111686115A (en) * 2020-07-08 2020-09-22 江西省妇幼保健院 Medicine for treating adenomyosis and application
WO2025088072A1 (en) 2023-10-25 2025-05-01 Ferring B.V. Compositions comprising progesterone and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4038389A (en) * 1975-05-07 1977-07-26 The Upjohn Company Medroxyprogesterone acetate compositions
ZA924811B (en) * 1991-06-28 1993-12-29 Endorecherche Inc Controlled release systems and low dose androgens
US5543150A (en) * 1993-09-15 1996-08-06 Columbia Laboratories, Inc. Method of progesterone delivery and affect thereof
DK0792152T3 (en) * 1994-11-22 2004-07-12 Balance Pharmaceuticals Inc Procedures for Pregnancy Prevention
US6416778B1 (en) * 1997-01-24 2002-07-09 Femmepharma Pharmaceutical preparations and methods for their regional administration

Also Published As

Publication number Publication date
CN1845723B (en) 2010-07-21
ZA200602695B (en) 2007-06-27
CN1845723A (en) 2006-10-11

Similar Documents

Publication Publication Date Title
TNSN06070A1 (en) Methods for the treatment of endometriosis
EP2261236A3 (en) Composition for proteasome inhibition
WO2004012582A3 (en) Systems, methods, and compositions for achieving closure of suture sites
IL156014A0 (en) Suturing instrument and method
WO2006084166A3 (en) Surgical implants and related methods and systems
MX2009005881A (en) Non-nucleoside reverse transcriptase inhibitors.
WO2006089023A3 (en) Pharmaceutical compositions for treating or preventing bone conditions
ATE448686T1 (en) ACTRIIB FUSION POLYPEPTIDES AND USES THEREOF
PH12013500123A1 (en) Hemiasterlin derivatives and uses thereof
UA88463C2 (en) Pharmaceutical composition comprising compound i and method of treating hiv infection
WO2008079270A3 (en) Coadministration of alpha-fetoprotein and an immunomodulatory agent to treat multiple sclerosis
DE60205899D1 (en) 1-biaryl-1,8-naphthyridin-4-one als phosphodieseterase-inhibitoren
WO2006113552A3 (en) Cyanoarylamines
MXPA05007771A (en) Methods for treating joint pain or improving sleep using an estrogen agonist/antagonist.
WO2005055953A3 (en) Methods of preventing and treating gastrointestinal dysfunction
TW200507840A (en) Method of treating multiple myeloma
WO2005030794A3 (en) Hemiasterlin derivatives and uses thereof
SI1532131T1 (en) Motilide compounds
TW200716088A (en) Formulations and methods for treating amyloidosis
WO2006108023A3 (en) Methods and compositions for modulating necdin function
WO2004067564A3 (en) Compositions against cancer antigen liv-1 and uses thereof
MXPA03001455A (en) Pyrazole compounds, pharmaceutical compositions, and methods for modulating or inhibiting erab or hadh2 activity.
WO2006128089A3 (en) Compositions and methods for treating tissue
UA90095C2 (en) Method for the treatment of endometriosis
EP1539714A4 (en) 8-HYDROXY-1-OXO-TETRAHYDROPYRROLOPYRAZINE COMPOUNDS AS INHIBITORS OF HIV INTEGRASE